Literature DB >> 3843988

Abbreviated surveillance of nosocomial urinary tract infections: a new approach.

E E Costel, S Mitchell, A B Kaiser.   

Abstract

An abbreviated method for the surveillance of nosocomial urinary tract infection is described. Combining desirable features of both active and passive surveillance, this new method involves concurrent review of microbiology reports. Compared to traditional active surveillance methods which require review of individual patient charts, the abbreviated method requires only one-fifth the time commitment while maintaining a 98% sensitivity. Although some degree of overestimation is inherent in this method, the primary goals of surveillance--monitoring infection rates and identifying clusters of infection--should be preserved.

Entities:  

Mesh:

Year:  1985        PMID: 3843988     DOI: 10.1017/s0195941700062433

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  5 in total

1.  Surveillance of hospital-associated infections.

Authors:  B Nyström
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

2.  Antibiotic susceptibility of Escherichia coli isolates from inpatients with urinary tract infections in hospitals in Addis Ababa and Stockholm.

Authors:  S Ringertz; B Bellete; I Karlsson; G Ohman; M Gedebou; G Kronvall
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Intensive care unit-acquired urinary tract infections in a regional critical care system.

Authors:  Kevin B Laupland; Sean M Bagshaw; Daniel B Gregson; Andrew W Kirkpatrick; Terry Ross; Deirdre L Church
Journal:  Crit Care       Date:  2005-01-06       Impact factor: 9.097

Review 4.  Urinary tract infections in the critical care unit: A brief review.

Authors:  Satyen Parida; Sandeep Kumar Mishra
Journal:  Indian J Crit Care Med       Date:  2013-11

Review 5.  Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review.

Authors:  Stéphanie Larramendy; Valentine Deglaire; Paul Dusollier; Jean-Pascal Fournier; Jocelyne Caillon; François Beaudeau; Leïla Moret
Journal:  Infect Drug Resist       Date:  2020-11-03       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.